Company Overview - Stevanato Group S.p.A. is a leading entity in the pharmaceutical and healthcare industry, known for its production of glass containers and integrated systems for drug delivery, with a strong global presence and innovative solutions [1] Financial Performance - The recent Q4 2025 earnings call provided insights into Stevanato Group's financial performance, discussing revenue, profit margins, and future outlook, which are crucial for understanding the company's operational strategies and market conditions [3] - Stevanato Group's market capitalization stands at approximately $4.37 billion, with a trading volume of 388,631 shares, indicating significant stock volatility over the past year [4][5] Stock Performance - Paul Knight from KeyBanc set a price target of $32 for STVN, suggesting a potential price increase of approximately 99.88%, while the stock is currently priced at $15.99, reflecting a decrease of 8.63% today [2][5] - Over the past year, the stock has reached a high of $28 and a low of $13.91, indicating the potential for significant price movements [4]

Palantir Technologies Inc. (PLTR) closed the last trading session at $153.19, gaining 9.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $200.41 indicates a 30.8% upside potential.The mean estimate comprises 22 short-term price targets with a standard deviation of $33.93. While the lowest estimate of $90.00 indicates a 41.3% decline from the current price level, the most optimist ...

Shares of Enovis (ENOV) have gained 13.1% over the past four weeks to close the last trading session at $25.79, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.55 indicates a potential upside of 76.6%.The mean estimate comprises 11 short-term price targets with a standard deviation of $6.47. While the lowest estimate of $33.00 indicates a 28% increase from the current price ...

Shares of Global-e Online Ltd. (GLBE) have gained 2.2% over the past four weeks to close the last trading session at $34.64, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $48.92 indicates a potential upside of 41.2%.The mean estimate comprises 13 short-term price targets with a standard deviation of $6.93. While the lowest estimate of $40.00 indicates a 15.5% increase from the ...

Monro Muffler Brake (MNRO) closed the last trading session at $20.07, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.63 indicates a 27.7% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $10.08. While the lowest estimate of $17.50 indicates a 12.8% decline from the current price level, the most optimistic anal ...

Shares of Replimune Group, Inc. (REPL) have gained 2.7% over the past four weeks to close the last trading session at $7.16, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $12.86 indicates a potential upside of 79.6%.The average comprises seven short-term price targets ranging from a low of $10.00 to a high of $19.00, with a standard deviation of $3.02. While the lowest estimat ...

Prothena (PRTA) closed the last trading session at $9.4, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $20.5 indicates an 118.1% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $10.65. While the lowest estimate of $8.00 indicates a 14.9% decline from the current price level, the most optimistic analyst expects th ...

Shares of BioLife Solutions, Inc. (BLFS) have gained 11% over the past four weeks to close the last trading session at $24.2, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $32.67 indicates a potential upside of 35%.The mean estimate comprises nine short-term price targets with a standard deviation of $1. While the lowest estimate of $31.00 indicates a 28.1% increase from the c ...

Shares of HCI Group (HCI) have gained 11.2% over the past four weeks to close the last trading session at $176.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $231.67 indicates a potential upside of 31.3%.The average comprises three short-term price targets ranging from a low of $205.00 to a high of $255.00, with a standard deviation of $25.17. While the lowest estimate indi ...

Aecom Technology (ACM) closed the last trading session at $99.56, gaining 2.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $129.08 indicates a 29.7% upside potential.The mean estimate comprises 12 short-term price targets with a standard deviation of $12.09. While the lowest estimate of $110.00 indicates a 10.5% increase from the current price level, the most optimistic analyst ...